Topical ozone: a lever to optimize the outcomes of a SARME?
Surgically Assisted Rapid Maxillary Expansion (SARME) is a key procedure for correcting transverse deficiencies, but its sequelae — pain, edema, and trismus — heavily impact perioperative comfort. For the oral surgeon, limiting this morbidity is a daily challenge. Ozone therapy, through its biological properties, emerges as a promising adjuvant solution to accelerate tissue recovery.
This retrospective study evaluated the impact of topical ozone on the recovery of 20 patients (aged 16 to 24 years) who underwent SARME. The objective was to determine whether postoperative ozone exposure positively influences clinical healing markers by comparing two cohorts: an ozone group (n=10) and a control group (n=10).
The hypothesis tested is based on the ability of ozone to significantly reduce pain scores (VAS scale), the extent of facial swelling, and the severity of trismus, while improving the quality of soft tissue healing compared to a standard protocol. The study thus seeks to validate whether this topical treatment constitutes an effective clinical tool for improving the patient experience during invasive maxillofacial procedures.
Study protocol
This retrospective study analyzed the clinical records of 20 patients (16 females and 4 males), aged 16 to 24 years, who underwent surgically assisted rapid maxillary expansion (SARME). The sample was divided into two groups of equal size:
- Ozone Group (n=10): patients who received topical ozone therapy during the postoperative phase.
- Control Group (n=10): patients who did not receive this adjuvant treatment.
Clinical parameters were evaluated on the 2nd, 4th, and 7th postoperative days. Measurements focused on:
- Pain: patient self-assessment via the visual analogue scale (VAS).
- Facial edema: measurement of distances between specific extra-oral reference points.
- Trismus: evaluation of the recovery of the mouth opening measured in millimeters.
- Healing: clinical evaluation of soft tissues using the Landry, Turnbull and Howley index.
Pour l'analyse des données, les auteurs ont utilisé des méthodes statistiques non paramétriques et des tests de permutation exacte, avec l'application systématique d'un ajustement de Holm-Bonferroni pour les comparaisons multiples.
Results: A marked clinical improvement from the 4th day
The retrospective analysis included 20 patients (16 women, 4 men) aged 16 to 24 years, equally divided between the ozone group (n=10) and the control group (n=10). The collected data show distinct healing kinetics depending on topical ozone exposure.
Short-term evaluation (D2)
On the second postoperative day, no statistically significant difference was observed between the ozone group and the control group regarding the following parameters:
- Pain scores (VAS scale);
- Facial edema changes;
- Recovery of mouth opening (trismus measurement);
- Clinical soft tissue healing scores (Landry, Turnbull and Howley index).
Evolution at D4 and D7
From the fourth day until the seventh postoperative day, the application of topical ozone is associated with significant clinical benefits compared to the control group. The results indicate:
- Pain: Significantly lower VAS scores in the ozone group.
- Inflammation: A less significant increase in facial oedema in treated patients.
- Function: A more favorable recovery of mouth opening.
- Healing: Significantly higher clinical healing scores, validating a better soft tissue response.
To equip yourself
Delynov products related to this theme:
- Rack for surgical screws of diameters 1.5 and 2.0 mm for maxillofacial surgery - Helmut Zepf (85.540.55) - Delynov (Screw organization for oral and maxillofacial surgery)
Delynov SurgeryWelcome to Delynov, your supplier for dental surgery, implantology, and periodontology. surgical suture threads absorbable and non-absorbable, consumables and instruments for dental and implant surgery.
| Parameters evaluated | Results at Day 2 | Results at D4 and D7 |
|---|---|---|
| Pain (VAS) | Not significant | Significant reduction (Ozone) |
| Facial oedema | Not significant | Lower augmentation (Ozone) |
| Trismus (Opening mm) | Not significant | Better recovery (Ozone) |
| Healing (Landry et al.) | Not significant | Higher scores (Ozone) |
The study highlights that while the effect of ozone is not immediate (no difference at D2), its impact on reducing postoperative complications of surgically assisted rapid maxillary expansion (SARME) becomes predominant during the critical healing phase between the 4th and 7th day.
Discussion: Ozone, a lever for the intermediate recovery phase
The results of this retrospective study indicate that topical ozone therapy acts less as an immediate preventive agent than as an accelerator of inflammatory resolution. The absence of a significant difference at D2 suggests that the initial peak of oedema and pain remains unchanged by the treatment. In contrast, the marked improvement observed at D4 and D7 on the VAS score, mouth opening, and clinical healing shows that ozone promotes more favourable recovery kinetics during the tissue transition phase.
From a clinical perspective, these data are consistent with observations made in third molar surgery (Kazancioglu et al., Sivalingam et al.), confirming the potential of ozone to improve post-operative comfort in oral and maxillofacial surgery. The reduction in facial oedema and the gain in mouth opening from the fourth day are concrete benefits for patients undergoing SARPE, a procedure often associated with significant post-operative morbidity.
The limitations of the study lie primarily in its retrospective nature and the modest size of the cohort (n=20). Furthermore, the female predominance (80%) could influence the reported perception of pain. Although the associations are clear for this case series, they require validation through prospective randomized clinical trials with greater statistical power to confirm the integration of ozone therapy into standardized peri-operative care protocols.
In concrete terms, for the practitioner:
- Offer topical ozone as an adjuvant post-SARPE to accelerate functional and tissue recovery between the 4th and 7th day.
- Manage patient expectations: specify that the effect on pain and swelling is not immediate (ineffective at D2) but becomes significant by the middle of the first week.
- Use this non-pharmacological option to improve overall postoperative comfort, particularly in managing trismus during the active healing phase.
Technical lexicon
SARME (Surgically Assisted Rapid Maxillary Expansion): Surgical procedure aimed at widening the upper maxilla by combining an osteotomy and the use of a palatal expander.
Topical ozone therapy: Local application of ozone (in gaseous or oily form) leveraging its antimicrobial and bio-stimulating properties to promote healing.
Landry, Turnbull and Howley Index: Clinical index used to evaluate the quality of gingival healing based on tissue color, bleeding, and the presence of granulation tissue.
Trismus: Involuntary limitation of mouth opening, common after maxillofacial surgery due to inflammation of the masticatory muscles.
Holm-Bonferroni adjustment: Statistical correction method used in multiple testing to reduce the risk of obtaining false-positive results.
Visual Analogue Scale (VAS): Pain measurement tool allowing the patient to position their sensation on a slider between 'no pain' and 'worst imaginable pain'.
Source
- Original title: Association of Topical Ozone Therapy with Postoperative Pain, Swelling, Trismus, and Wound Healing After SARME: A Retrospective Clinical Study
- Authors: Mehmet Şah Kayabaşı, Saim Yanık
- Publication: European Journal of Therapeutics - 2026-08-06
- DOI: https://doi.org/10.58600/eurjther3088
Also read in the Delynov blog
Muskan Chanduka, Shweta Nagesh, CH Lalitha, Balaram Kolasani, Ravindranath Dhulipalla, Ra…
Fractal analysis: a new predictive tool for rapid palatal expansion
Ying Liang, Ting Liu, Unman Chan, Yuzheng Xie, Rong Deng, Xun Wang, Qi Feng, Tianfeng Che…
The innovation of selenium nanoparticles to stabilize rapid maxillary expansion
Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility regarding the use of this information. This document is not intended for patients or the general public.



















